Express Scripts Holding Co (ESRX)

ESRX (NASDAQ:Health Services) EQUITY
$87.14
neg -2.09
-2.34%
Today's Range: 86.16 - 89.70 | ESRX Avg Daily Volume: 3,933,400
Last Update: 05/29/15 - 4:00 PM EDT
Volume: 8,329,283
YTD Performance: 5.39%
Open: $89.20
Previous Close: $89.23
52 Week Range: $65.08 - $91.21
Oustanding Shares: 729,291,000
Market Cap: 65,439,281,430
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 11 11 11
Moderate Buy 3 3 3 3
Hold 7 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.83 1.73 1.73 1.73
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 31.82
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
31.82 31.70 26.97
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.24% 25.52% 69.54%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.10 1.19 0.29
Net Income 8.70 0.60 0.17
EPS 17.90 0.05 0.02
Earnings for ESRX:
EBITDA 5.85B
Revenue 100.89B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.38 $1.43 $5.43 $6.01
Number of Analysts 13 14 17 17
High Estimate $1.42 $1.47 $5.47 $6.15
Low Estimate $1.14 $1.40 $5.37 $5.92
Prior Year $1.23 $1.29 $4.88 $5.43
Growth Rate (Year over Year) 12.57% 10.80% 11.37% 10.65%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

A Downturn Looks Imminent Real Money Pro($)

Monday's action went nowhere, in an extremely narrow trading range.
The easy money was made buying during 2012 when many stayed away.
It will get worse in magnitude and in frequency.

Liable to Bounce Real Money Pro($)

These six stocks look set to reverse as they approach their key respective moving-average lines.
Bullish
Jul 30, 2013 | 8:04 AM EDT
ESRX earnings estimates were raised to reflect raised guidance, but slightly lower Rx claims growth, said UBS. Price target is $75.

Early-Morning Market Look Real Money Pro($)

Let's start by taking a peek at the overnight and early-morning price action of the major asset classes.
The numbers don't lie.

The GAAP vs. Non-GAAP Dilemma Real Money Pro($)

Which figures should you use to make investment decisions?

Sell Signal? Real Money Pro($)

A normally reliable short-term indicator looks bearish.
Bullish
May 13, 2013 | 7:59 AM EDT
ESRX was upgraded from Hold to Buy, Jefferies said. $74 price target. Uncertainty is gone and the company should resume share repurchas...

Columnist Conversations

Ford continues to underwhelm. The stock has been in a steady drift lower since its March 23rd high. This...
This past week, 10-year YIELD broke and sustained below key support at 2.18% - 2.15%, and has continued lower ...
Eli Lilly is trading at new 52 week highs today. The drug manufacturer is up over 3.25% and is near the to...
On May 15 and 18 I mentioned here about adding some Jun 29 calls, our price was 1.75. The chart was outstandi...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.